• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Henry Schein Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    5/5/25 6:14:20 AM ET
    $HSIC
    Medical Specialities
    Health Care
    Get the next $HSIC alert in real time by email
    hsic-20250505
    0001000228 false NASDAQ 0001000228 2025-05-05 2025-05-05
     
     
     
     
     
     
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON,
     
    D.C. 20549
    FORM
    8-K
    CURRENT REPORT
     
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported):
    May 5, 2025
    Henry Schein, Inc.
    (Exact name of registrant as specified in its charter)
     
    Delaware
    (State or other jurisdiction
    of incorporation)
     
    0-27078
    (Commission
    File Number)
     
    11-3136595
    (IRS Employer
    Identification No.)
     
     
     
     
     
    135 Duryea Road
    ,
    Melville
    ,
    New York
    (Address of principal executive offices)
    11747
    (Zip Code)
    Registrant’s telephone number, including area code: (
    631
    )
    843-5500
    (Former name or former address, if changed since last
     
    report.)
    Check the appropriate box
     
    below if the
     
    Form 8-K filing is intended to simultaneously satisfy
     
    the filing obligation of
     
    the registrant under any
     
    of the following
    provisions:
    ☐
     
    Written communications pursuant
     
    to Rule 425
     
    under the Securities
     
    Act (17 CFR 230.425)
    ☐
     
    Soliciting material pursuant to
     
    Rule 14a-12 under
     
    the Exchange Act (17
     
    CFR 240.14a-12)
    ☐
     
    Pre-commencement communications pursuant to
     
    Rule 14d-2(b) under
     
    the Exchange Act
     
    (17 CFR 240.14d-2(b))
    ☐
     
    Pre-commencement communications pursuant to
     
    Rule 13e-4(c) under the
     
    Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to
     
    Section 12(b) of the
     
    Act:
    Title of each class
     
    Trading
    Symbol(s)
     
    Name of each exchange
    on which registered
    Common Stock, par value $.01 per share
     
    HSIC
     
    The
    Nasdaq
     
    Global Select Market
    Indicate by check mark whether the registrant is an emerging growth
     
    company as defined in Rule 405 of the Securities Act
     
    of 1933 (§230.405 of this chapter) or Rule
    12b-2 of the Securities Exchange Act of 1934 (§240.12b-2
     
    of this chapter).
    Emerging growth company
     
    ☐
    If an emerging growth company,
     
    indicate by check mark if the registrant has
     
    elected not to use the extended transition period
     
    for complying with any new or revised
    financial accounting standards provided pursuant to Section 13(a) of
     
    the Exchange Act.
     
    ☐
     
    Item 2.02.
     
    Results of Operations and Financial Condition.
    On May 5, 2025, Henry Schein, Inc. issued a press release reporting
     
    the financial results for the three months
    ended March 29, 2025.
     
    The full text of the press release is attached hereto as Exhibit
     
    99.1 and is incorporated herein by
    reference.
    The information in this Item 2.02 and the press release attached as Exhibit
     
    99.1 are considered furnished to the
    Securities and Exchange Commission and are not deemed filed for purposes
     
    of Section 18 of the Securities Exchange
    Act of 1934, as amended.
    Item 9.01.
     
    Financial Statements and Exhibits
    (a)
     
    Not applicable.
    (b)
     
    Not applicable.
    (c)
     
    Not applicable.
    (d)
     
    Exhibit 99.1 – Press Release dated May 5, 2025.
    Exhibit 104 - Cover Page Interactive Data File (embedded within the
     
    Inline XBRL document)
    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the
     
    registrant has duly caused this report to
    be signed on its behalf by the undersigned hereunto duly authorized.
    HENRY SCHEIN, INC.
    By:
    /s/ Ronald N. South
    Ronald N. South
    Senior Vice President and
    Chief Financial Officer
    (Authorized Signatory and Principal
    Financial and Accounting Officer)
    May 5, 2025
    EXHIBIT INDEX
    Exhibit No.
    Description
    99.1
    Press Release dated May 5, 2025.
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL
     
    document)
    Get the next $HSIC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HSIC

    DatePrice TargetRatingAnalyst
    2/14/2025$80.00Equal Weight
    Wells Fargo
    1/6/2025$69.00 → $84.00Underperform → Buy
    BofA Securities
    12/4/2024$75.00Neutral
    Mizuho
    7/22/2024$81.00 → $92.00Neutral → Outperform
    Robert W. Baird
    2/26/2024$78.00Market Perform
    Leerink Partners
    12/12/2023$71.00 → $82.00Neutral → Overweight
    JP Morgan
    11/10/2023$70.00Hold → Buy
    Stifel
    8/8/2022$80.00Sell → Neutral
    UBS
    More analyst ratings